Distinguish typhoid vaccine Drugbox Verifiedfields changed verifiedrevid 365989659 image Vacine data type vaccine target Typhus vaccine type inactivated Clinical data tradename pregnancy AU A B1 B2 B3 C D X pregnancy US A B C D X pregnancy category legal AU S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled legal CA Schedule I, II, III, IV, V, VI, VII, VIII legal UK GSL, P, POM, CD, or Class A, B, C legal US OTC Rx only Schedule I, II, III, IV, V legal status routes of administration Identifiers ChemSpiderID Ref chemspidercite changed chemspider ChemSpiderID NA CAS number Ref cascite correct ?? CAS number ATC prefix J07 ATC suffix AR01 PubChem DrugBank Ref drugbankcite correct drugbank DrugBank Chemical data Typhus vaccine is a vaccine used against typhus . ref name pmid17375000 cite journal author Chattopadhyay S, Richards AL title Scrub typhus vaccines past history and recent developments journal Hum Vaccin volume 3 issue 3 pages 73 80 year 2007 pmid 17375000 doi url http www.landesbioscience.com journals hv abstract.php?id 4009 ref ref name pmid16481526 cite journal author Xu G, Chattopadhyay S, Jiang J, et al. title Short and long term immune responses of CD 1 outbred mice to the scrub typhus DNA vaccine candidate p47Kp journal Ann. N. Y. Acad. Sci. volume 1063 issue pages 266 9 year 2005 month December pmid 16481526 doi 10.1196 annals.1355.043 url http www3.interscience.wiley.com resolve openurl?genre article&sid nlm pubmed&issn 0077 8923&date 2005&volume 1063&spage 266 ref One version of the vaccine consists of formaldehyde inactivated Rickettsia prowazekii. Two doses are injected subcutaneously four weeks apart. Booster doses are required every six to twelve months. References reflist Vaccines Category Vaccines vaccine stub ... more details
DA2PP, also known as DHPP, is a Vaccine Valence multivalent vaccine for dog s that protects against canine distemper , adenovirus Animals adenovirus type 2 , Kennel cough parainfluenza , canine parvovirus , and canine coronavirus . This vaccine is usually given to puppies at 8 weeks of age, followed by 12 weeks of age, and then 16 weeks of age. This vaccine is given again at 1 year of age and then annually, or every 3 years. Some veterinarians recommended vaccine schedules may differ from this. Some Holistic veterinarians may recommend only one shot. http www.organic pet digest.com dog vaccination schedule.html http www.moonstruckmeadows.com RecommendedVaccinations.htm http www.dogs4dogs.com puppy shots.htm For distemper While the DA2PPC vacine also protects against parainfluenza, parvovirus , adenovirus , and canine coronavirus , it most importantly protects against the debilitating and deadly disease canine distemper, a often fatal viral illness that causes neurologic dysfunction, pneumonia , nonspecific systemic symptoms such as fever and fatigue, and weight loss, as well as upper respiratory symptoms and diarrhea, poor appetite, and vomiting. There is no antiviral drug effective against the canine distemper virus. Treatment is supportive and consists of antibiotics to prevent secondary infections , anticonvulsants for seizures, and intravenus fluids to prevent dehydration . Given the lethality of distemper and the relative rarity of side effects from the vaccine, all reputable veterinarians recommend the DA2PPC vaccine. Also, even if the dog owner is not concerned about adenovirus, coronavirus, parvovirus, or parainfluenza, they should vaccinate their dogs to protect them against distemper. Notes reflist DEFAULTSORT Da2ppc Vaccine Category Animal vaccines veterinary med stub ... more details
A Cytomegalovirus vaccine is a vaccine against cytomegalovirus CMV such a vaccine is currently under investigation. ref name pmid17547509 cite journal author Zhong J, Khanna R title Vaccine strategies against human cytomegalovirus infection journal Expert Rev Anti Infect Ther volume 5 issue 3 pages 449 59 year 2007 month June pmid 17547509 doi 10.1586 14787210.5.3.449 url http www.future drugs.com doi abs 10.1586 14787210.5.3.449?url ver Z39.88 2003&rfr id ori rid crossref.org&rfr dat cr pub 3dncbi.nlm.nih.gov ref ref name pmid18806877 cite journal author Zhong J, Rist M, Cooper L, Smith C, Khanna R title Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus journal PLoS ONE volume 3 issue 9 pages e3256 year 2008 pmid 18806877 pmc 2533118 doi 10.1371 journal.pone.0003256 url http www.plosone.org article info doi 10.1371 journal.pone.0003256 ref As a member of the TORCH complex , cytomegalovirus can cause congenital infection. Because of this, there has been considerable effort made towards the development of a vaccine ... Schleiss MR title Comparison of vaccine strategies against congenital CMV infection in the guinea ..., members of this population are less likely to be candidates for such a vaccine. Development of such a vaccine has been emphasized as a priority by the National Vaccine Program Office in the United ... vaccine time to look for alternative options journal Trends Mol Med volume 12 issue 1 pages 26 33 ... P, Myers M, Plotkin S, Rabinovich R title Vaccine development to prevent cytomegalovirus disease report from the National Vaccine Advisory Committee journal Clin. Infect. Dis. volume 39 issue 2 pages ... cytomegalovirus dense body vaccine journal Med. Microbiol. Immunol. volume 197 issue 2 pages ... vaccine published in 2009 indicated an efficacy of 50 , thus the protection provided was limited ... CMV was encountered. ref cite journal author Pass RF, Zhang C, Evans A, et al title Vaccine prevention ... more details
the disease. ref http www.who.int vaccine research diseases zoonotic en index5.html ref Many areas ... reflist Vaccines Category Vaccines vaccine stub ... more details
Drugbox Verifiedfields changed Watchedfields changed verifiedrevid 446094983 image Vacine data type vaccine target Cholera vaccine type killed Clinical data tradename Drugs.com drugs.com CONS cholera vaccine pregnancy AU A B1 B2 B3 C D X pregnancy US C pregnancy category legal AU S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled legal CA Schedule I, II, III, IV, V, VI, VII, VIII legal UK GSL, P, POM, CD, or Class A, B, C legal US OTC Rx only Schedule I, II, III, IV, V legal status routes of administration Identifiers CAS number Ref cascite correct ?? CAS number ATC prefix J07 ATC suffix AE01 ATC supplemental ATC J07 AE02 PubChem DrugBank Ref drugbankcite correct drugbank DrugBank ChemSpiderID Ref chemspidercite changed chemspider ChemSpiderID NA Chemical data Cholera vaccine is a vaccine used against cholera ref MeshName Cholera vaccines ref and traveler s diarrhea . The first vaccines against cholera were developed in the late nineteenth century. These injected whole cell vaccine became increasingly popular until they were replaced by oral vaccines starting in the 1980s. Although no longer ... pmid 20687062 ref There are two variants of the oral vaccine currently in use WC rBS and BivWC. WC rBS marketed as Dukoral is a monovalent inactivated vaccine containing killed whole cells of Vibrio ... and mORCVAX is a bivalent inactivated vaccine containing killed whole cells of V. cholerae O1 and V ... Tor and Classical biotypes are included in the vaccine. Dukoral is taken orally with bicarbonate buffer, which protects the antigens from the gastric acid. The vaccine acts by inducing antibodies against ... s diarrhea . The cholera vaccine is largely used by backpackers and persons visiting locations where ... described as moderate , herd immunity can multiply the effectiveness of vaccination. Although the vaccine can be dangerous for children, administration of the vaccine to adults can confer protection to children indirectly. References reflist 2 Vaccines Category Vaccines vaccine stub ar ... more details
An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen , but still keeping it viable or live . ref name pmid12239331 cite journal author Badgett MR, Auer A, Carmichael LE, Parrish CR, Bull JJ title Evolutionary dynamics of viral attenuation journal J. Virol. volume 76 issue 20 pages 10524 9 year 2002 month October pmid 12239331 pmc 136581 doi 10.1128 JVI.76.20.10524 10529.2002 url http jvi.asm.org cgi pmidlookup?view long&pmid 12239331 ref Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by killing the virus inactivated vaccine . Examples Examples of live example attenuated vaccines include Viral measles vaccine , mumps vaccine , rubella vaccine , chicken pox vaccine , oral polio vaccine Sabin , yellow fever vaccine , ref name urlImmunization cite web url http pathmicro.med.sc.edu ghaffar immunization ver2.htm title Immunization work accessdate 2009 03 10 ref and nasal spray flu vaccine including the Influenza vaccine seasonal flu nasal spray and the Influenza A virus subtype H1N1 2009 H1N1 flu nasal spray . Rabies vaccine s are now available in two different attenuated forms, one for use in humans, and one for animal usage. Bacterial BCG vaccine , ref name urlImmunization typhoid vaccine ref name pmid17582564 cite journal author Levine MM, Ferreccio C, Black RE, Lagos R, San Martin O, Blackwelder WC title Ty21a live oral typhoid vaccine and prevention of paratyphoid ... in the wild . Administration In an attenuated vaccine, live virus particles with very low ... to transport administer for instance Polio Vaccine OPV for Polio can be taken orally, rather than ... al. title Circulation of type 1 vaccine derived poliovirus in the Philippines in 2001 journal J. Virol ... Polio Eradication Initiative Advantages and Disadvantages of Vaccine Types http www.cdc.gov h1n1flu vaccination nasalspray qa.htm CDC H1N1 Flu 2009 H1N1 Nasal Spray Vaccine Q&A at the website of the US ... more details
Y 59 y 40 ICD9 ICD9 E948 , ICD9 E949 ICDO OMIM MedlinePlus eMedicineSubj eMedicineTopic MeshID A vaccine injury is an injury caused by vaccination . Allegations of vaccine injuries in recent decades ... unfounded. ref name Sugarman In response, several vaccine makers stopped production, threatening public health , and laws were passed to shield makers from Legal liability liabilities stemming from vaccine ... the condition, and underestimating the potential harm to those whom the vaccine could protect ... confidence in the vaccine. ref name Bonhoeffer Controversies in this area revolve around the question ... can cause serious adverse effects, such as gelatin measles mumps rubella vaccine MMR causing anaphylaxis ... author Bonhoeffer J, Heininger U doi 10.1097 QCO.0b013e32811ebfb0 pmid 17471032 ref Vaccine ... particularly focus on the MMR vaccine controversy MMR vaccine and on Thimerosal controversy thiomersal ... of age. ref cite journal journal Vaccine date 2008 volume 26 issue 3 pages 427 9 title Inactivated influenza vaccine IIV in children 2 years of age examination of selected adverse events reported to the Vaccine Adverse Event Reporting System VAERS after thimerosal free or thimerosal containing vaccine author McMahon AW, Iskander JK, Haber P, Braun MM, Ball R doi 10.1016 j.vaccine.2007.10.071 ... from a Vaccine court federal fund , saying that their health problems were caused by common childhood ... immunizations against nine diseases. ref cite news author Stobbe M, Marchione M title Analysis vaccine ... 2008 03 07 analysis vaccine payment no landmark accessdate 2008 06 06 ref ref cite journal journal ... States Vaccine Injury Compensation Program In 1988, the Vaccine court National Vaccine Injury ... 33 issue 2 pages 199 211 title Update on the National Vaccine Injury Compensation Program author ... to an earlier scare over the pertussis portion of the DPT vaccine. These claims were later generally discredited, but some U.S. lawsuits against vaccine makers won substantial awards most makers ceased ... more details
Drugbox Verifiedfields changed verifiedrevid 402053071 image Vacine data type vaccine target Bordetella pertussis vaccine type varies Clinical data tradename MedlinePlus a682198 pregnancy AU A B1 B2 B3 C D X pregnancy US A B C D X pregnancy category legal AU S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled legal CA Schedule I, II, III, IV, V, VI, VII, VIII legal UK GSL, P, POM, CD, or Class A, B, C legal US OTC Rx only Schedule I, II, III, IV, V legal status routes of administration Identifiers ChemSpiderID Ref chemspidercite changed chemspider ChemSpiderID NA CAS number Ref cascite correct ?? CAS number ATC prefix J07 ATC suffix AJ01 ATC supplemental ATC J07 AJ02 PubChem DrugBank Ref drugbankcite correct drugbank DrugBank Chemical data Pertussis vaccine is a vaccine used against Bordetella pertussis . ref name urlMedlinePlus Medical Encyclopedia Pertussis vaccine cite web url http www.nlm.nih.gov medlineplus ency article 001561.htm title MedlinePlus Medical Encyclopedia Pertussis work accessdate 2010 07 02 ref It is a component of the DPT vaccine . Older versions of the vaccine involved inactivated cells. Newer versions are acellular, and are less likely to provoke a febrile state. ref cite journal author Patel SS, Wagstaff AJ title Acellular pertussis vaccine Infanrix DTPa SB 3 . A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella ... In 2005, two new vaccine products were licensed for use in adolescents and adults that combine the tetanus and diphtheria toxoids with acellular pertussis Tdap vaccine. These vaccines are the first ... are much less common with acellular DTaP vaccine however, a determination of more rare adverse effects ... pertussis vaccine efficacy range from 84 to 85 in preventing typical whooping cough a level believed to be far more efficacious than the previously used whole cell pertussis vaccine. ref cite ... CD001478 doi 10.1002 14651858.CD001478.pub5 pmid 22419280 ref References Reflist Vaccines vaccine ... more details
A pneumococcal vaccine is a vaccine against Streptococcus pneumoniae . ref MeshName Pneumococcal Vaccines ref Types include Pneumococcal polysaccharide vaccine Pneumococcal conjugate vaccine Vaccination in the USA In the USA, a heptavalent pneumococcal conjugate vaccine PCV 7 e.g. Prevenar ref E.M.E.A. ... months of age. In February 2010, a pneumococcal congugate vaccine which protects against an additional ... that is not contained in the vaccine, he she is not afforded any protection. This limitation ... polysaccharide vaccine Pneumovax is one brand gives at least 85 protection in those under 55 ..., including those 65 years or older generally the vaccine should be a single lifetime dose, as there is a high ... introduce vaccination with the conjugate vaccine in children aged 2, 4 and 13 months. ref name BBCVac http news.bbc.co.uk 1 hi health 4692908.stm Children to be given new vaccine BBC News , February ... PressReleases PressReleasesNotices fs en?CONTENT ID 4128036&chk PI8e57 Pneumococcal vaccine added ..., the European Medicines Agency approved the use of a 10 valent pneumcoccal conjugate vaccine for use in Europe. ref Synflorix, GlaxoSmithKline s pneumococcal vaccine receives European authorisation ... vaccine has been introduced in the routine immunisation schedule of the UK in April 2010. Vaccination .... ref name PneumoADIP website http www.pneumoadip.com PneumoADIP website ref Vaccine research Due ... efficacious vaccine for developing world populations. In a previous study, the most common pneumococcal ... site pneumococcal isolates from children implications for vaccine strategies journal Pediatr Infect ... 00007 ref In order to further pneumococcal vaccine research and reduce childhood mortality, five ... of a Pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection ... ref It is believed that this improves vaccine efficacy and also avoids the need for injection. The development ... in a Mouse Model of Systemic Pneumococcal Infection journal Clin Vaccine Immunol volume ... more details
Image United States Court of Federal Claims.JPG thumb 200px Cases before the Vaccine Court are heard in the U.S. Court of Federal Claims. Vaccine court is the popular term which refers to the Office of Special ... system for litigating vaccine injury claims. These claims against vaccine manufacturers cannot normally ... without a jury. The program was established by the 1986 National Childhood Vaccine Injury Act NCVIA , passed by the United States Congress in response to a threat to the vaccine supply due to a 1980s scare over the DPT vaccine . Despite the belief of most public health officials that claims of side effects were unfounded, large jury awards had been given to some plaintiffs, most DPT vaccine ... parents of children with autism spectrum disorder s have MMR vaccine controversy attributed the disorders ... demanded compensation from vaccine makers. However, the mainstream medical and scientific communities have consistently MMR vaccine controversy found no link between Vaccination schedule routine childhood vaccines and autism . ref name Doja National Childhood Vaccine Injury Act main National Childhood Vaccine Injury Act The U.S. Department of Health and Human Services set up the National Vaccine ... 2 pages 199 211 title Update on the National Vaccine Injury Compensation Program author Edlich RF ... portion of the DPT vaccine. ref name Sugarman These claims were later generally discredited, but some U.S. lawsuits against vaccine makers won substantial awards most makers ceased production, and the last ... insurance no fault system for resolving vaccine injury claims. ref name Sugarman Compensation covers ... has been funded by an excise tax of 75 cents on every purchased dose of covered vaccine. To win ... listed adverse effects soon after vaccination, the assumption is that it was caused by the vaccine .... ref name Sugarman The VICP covers all vaccines listed on the Vaccine Injury Table maintained ... , and pneumonia . ref cite web url http www.hrsa.gov vaccinecompensation table.htm title Vaccine ... more details
An adenovirus vaccine is a vaccine against Adenovirus . ref name pmid18251691 cite journal author Tucker SN, Tingley DW, Scallan CD title Oral adenoviral based vaccines historical perspective and future opportunity journal Expert Rev Vaccines volume 7 issue 1 pages 25 31 year 2008 month February pmid 18251691 doi 10.1586 14760584.7.1.25 url http www.future drugs.com doi abs 10.1586 14760584.7.1.25?url ver Z39.88 2003&rfr id ori rid crossref.org&rfr dat cr pub 3dncbi.nlm.nih.gov ref It was used by the United States military from 1971 to 1999, but was discontinued when the only manufacturer stopped production. ref name pmid16480793 cite journal author Russell KL, Hawksworth AW, Ryan MA, et al. title Vaccine preventable adenoviral respiratory illness in US military recruits, 1999 2004 journal Vaccine volume 24 issue 15 pages 2835 42 year 2006 month April pmid 16480793 pmc 1955759 doi 10.1016 j.vaccine.2005.12.062 url http linkinghub.elsevier.com retrieve pii S0264 410X 06 00016 8 ref ref name urlVaccine Trials For Boot Camp Crud May Help 20 Percent of Recruits cite web url http www.navy.mil search display.asp?story id 26369 title Vaccine Trials For Boot Camp Crud May Help 20 Percent of Recruits ... www.navy.mil search display.asp?story id 26369 archivedate 12 February 2009 DASHBot deadurl no ref This vaccine ... and Drug Administration approved an adenovirus vaccine manufactured by Teva Pharmaceuticals under contract to the U.S. Army. ref Malarkey MA, Baylor NW. FDA approval letter dated March 16, 2011. ref This vaccine ... services began administering the new adenovirus vaccine to recruits during basic training. It should ... Croyle MA, Patel A, Tran KN, et al. title Nasal Delivery of an Adenovirus Based Vaccine Bypasses Pre Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice journal PLoS ONE ... and vaccine applications journal Virus Res. volume 132 issue 1 2 pages 1 14 year 2008 month March ... as vaccine vectors journal Mol. Ther. volume 10 issue 4 pages 616 29 year 2004 month October pmid ... more details
data type vaccine target Rabies vaccine type killed Clinical data tradename Drugs.com drugs.com monograph rabies vaccine MedlinePlus a607023 pregnancy AU A B1 B2 B3 C D X pregnancy US A B C D X pregnancy ... BG01 PubChem DrugBank Ref drugbankcite correct drugbank DrugBank Chemical data Rabies vaccine is a vaccine .... Imrab is an example of a veterinary rabies vaccine containing the Pasteur strain of killed .... This vaccine was first used on a human on July 6, 1885, on nine year old Joseph Meister 1876 1940 ... Center pmid 348641 ref Their vaccine consisted of a sample of the virus harvested from infected and necessarily ... following anti rabies vaccine journal Neurol India volume 52 issue 1 pages 132 3 year 2004 month March ... issue 1 spage 132 epage 133 aulast Srivastava ref Modern vaccines The human diploid cell rabies vaccine ... Rabies Day. Retrieved 2010 04 23. ref developed and produced a dog vaccine that gave a three year immunity from rabies . The development of the vaccine resulted in the elimination of rabies in many ... expensive purified chicken embryo cell vaccine, and purified Vero cell rabies vaccine are now available. The purified Vero cell rabies vaccine uses the attenuated Wistar strain of the rabies virus, and uses the Vero cell line as its host. Recombinant rabies vaccine V RG Image Rabies vaccine in bait.jpg thumb Aerially distributed wildlife rabies vaccine in a bait from Estonia. In 1984 researchers at the Wistar Institute developed a Recombinant DNA recombinant vaccine called V RG by inserting the glycoprotein ... 6095272 doi 10.1073 pnas.81.22.7194 pmc 392104 ref The V RG vaccine has since been commercialised by Merial ... in wildlife . The vaccine is stable under relatively high temperatures and can be delivered orally ... http www.spmsd.co.uk file.asp?docid 140 Patient Group Direction Information for Rabies Vaccine BP Sanofi Pasteur MSD , page 3 ref ref http www.travelturtle.co.uk Vaccine Details.aspx?confoundingFactorId ... CATMAT STATEMENT ON TRAVELLERS AND RABIES VACCINE ref Following administration of a booster dose ... more details
Update date March 2011 An HIV vaccine that protects vaccination vaccinated individuals from HIV infection is the goal of many HIV research programmes. Currently, there is no effective vaccine against HIV, the virus that causes AIDS . Vaccine development is one of several strategies to reduce the worldwide ... campaigns. There is evidence that a vaccine may be possible. Work with monoclonal antibody monoclonal ... of the search for a vaccine against HIV stems from the AIDS related death toll of over 25 million ... AIDS epidemic, July 2004 ref Alternative medical treatments to a vaccine do exist. Highly active ..., an HIV vaccine is generally considered as the most likely, and perhaps the only way by which ... target for a vaccine. Difficulties in developing an HIV vaccine In 1984, after the confirmation ... that a vaccine would be available within two years. ref Shilts, Randy 1987 . And the Band Played On Politics ... in the case of HIV 1. Some have stated that an HIV vaccine may not be possible without significant theoretical advances. ref name pmid18441377 cite journal author Watkins DI title Basic HIV Vaccine ... that cause development of an HIV vaccine to differ from the development of other classic vaccines ref A. S. Fauci, 1996, An HIV vaccine breaking the paradigms, Proc. Am. Assoc. Phys. 108 6. ref Classic ... does not retain antigenicity and the use of a live retrovirus vaccine raises safety issues. Most vaccines .... Therefore, the immune responses raised by any vaccine need to be broad enough to account for this variability. Any vaccine that lacks this breadth is unlikely to be effective. The difficulties in stimulating a reliable antibody response has led to the attempts to develop a vaccine that stimulates ... M, Duerr A title HIV vaccine efficacy trials towards the future of HIV prevention journal Infect. Dis ... ref ref name pmid18425263 cite journal author Watkins DI title The hope for an HIV vaccine based ... L tourneau S title Design and Pre Clinical Evaluation of a Universal HIV 1 Vaccine journal PLoS ONE ... more details
trial Malaria vaccines are an area of intensive research. However, there is no effective vaccine ... and a cost effective deployable vaccine will be needed to facilitate eradication. There has been a great ... Measles measles initiatives. Yet no effective vaccine for malaria has so far been developed. Despite ... attenuate d sporozite s and using the RTS,S AS01 malaria vaccine candidate. Citation needed date December 2008 Agents under development A completely effective vaccine is not yet available for malaria ... CD005966 doi 10.1002 14651858.CD005966 journal Cochrane Database Syst Rev ref Other vaccine candidates ... vaccine shows longlasting protection Commercial name of RTS,S ref which started Pivotal Phase III ... areas who suffer the burden of disease and death related to malaria. The RTS,S vaccine was engineered ... ref ref Stein, R. http www.washingtonpost.com national health science experimental malaria vaccine protects many children study shows 2011 10 17 gIQA5NyguL story.html?hpid z1 Experimental malaria vaccine ... vaccine ref Considerations for vaccine development The task of developing a preventative vaccine ... strategy a potential vaccine should adopt. The diversity of the parasite P. falciparum has demonstrated ... of the key considerations necessary when considering potential vaccine candidates. The development of resistance could cause a significant reduction in efficacy of any potential vaccine thus rendering ... of an antibody response humoral immunity and a cell mediated immune response. Ideally a vaccine ... cell mediated response. Potential antigens against which a vaccine could be targeted will be discussed ... malaria. Thus a therapeutic vaccine could target the production of TNF a, preventing respiratory ... vaccine candidate would attempt to generate a more substantial cell mediated and antibody response ... the parasite. Potential targets of a vaccine By their very nature, parasites are more complex organisms ... problems in vaccine development but also increases the number of potential targets for a vaccine. These have ... more details
vaccine class1 Vaccine component2 Pertussis vaccine class2 Vaccine component3 Tetanus vaccine class3 Vaccine Clinical data tradename pregnancy AU A B1 B2 B3 C D X pregnancy US A B C D X legal AU ... and DTwP refers to a class of combination vaccine s against three infectious disease s in humans diphtheria , pertussis whooping cough and tetanus . The vaccine components include diphtheria and tetanus ... or TD vaccine , which lacks the pertussis component. In the Netherlands , the acronym DTP refers to a combination vaccine against diphtheria, tetanus, and poliomyelitis . There, pertussis is known as kinkhoest and DKTP refers to a combination vaccine against diphtheria, pertussis kinkhoest, tetanus .... ref name vaccine refusal cite news title Is Vaccine Refusal Worth The Risk? publisher NPR ... for fear of side effects ref name vaccine refusal however, most side effects of the vaccination are moderate .... ref name vaccine refusal In 1994, the Institute of Medicine of the US National Academy of Sciences ... seven days following vaccination with whole cell pertussis vaccine, the evidence was compatible ... also DTPa and TDaP is a combined vaccine against diphtheria, tetanus, and pertussis, in which the pertussis ... vaccine uses selected antigens of the pertussis pathogen to induce immunity. Because it uses ... needed date August 2009 Recent research suggests that the DTP vaccine is more effective than DTaP ... pathogen strains. The acellular vaccine is safer to administer in that it causes substantially ... for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis Tdap vaccine ... Tetanus, Diphtheria and Pertussis Tdap Vaccine for Adults date work publisher url http www.cdc.gov nip vaccine tdap tdap adult recs.pdf format PDF ref ref cite web author title Interval Between Administration ... of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory ... on Vaccine Safety publisher World Health Organization url http www.who.int vaccine safety topics thiomersal ... more details
Drugbox Verifiedfields changed Watchedfields changed verifiedrevid 445667873 image Vacine data type vaccine target Neisseria meningitidis the antigen bacteria toxin virus to protect against vaccine type ... drugs.com monograph meningococcal vaccine MedlinePlus a607020 pregnancy AU A B1 B2 B3 C D X ... DrugBank Chemical data Meningococcal vaccine is a vaccine used against Meningococcus , a bacterium ... Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086 journal ..., all quadrivalent in nature, targeting serogroups A, C, W 135 and Y two conjugate vaccine s MCV 4 , Menactra and Menveo, and one polysaccharide vaccine MPSV 4 , Menomune, produced by Sanofi Pasteur ..., but have not been licensed in the United States. The first meningococcal conjugate vaccine ... vaccine MPSV4 , Menomune, has been available since the 1970s. It may be used if MCV4 is not available, and is the only meningococcal vaccine licensed for people older than 55. Information about who should receive the meningococcal vaccine is available from the CDC. ref Menningococcal Vaccines ... of clinical protection after vaccination with meningococcal polysaccharide A vaccine journal ..., so boosters are not recommended with this vaccine. ref cite journal author Borrow R, Joseh H ... vaccine in adults journal Vaccine year 2000 volume 19 issue 9&ndash 10 pages 1129 32 pmid ... in Gambian children following repeated immunization during early childhood journal Vaccine year 1999 ... with quadrivalent meningococcal conjugate vaccine journal J Infect Dis volume 193 issue 6 pages 821 ... Centers for Disease Control and Prevention CDC ref Serogroup A A vaccine called MenAfriVac has been developed through a program called the Meningitis Vaccine Project and it is a good option for preventing ... epidemic Group A meningococcal meningitis in Africa through a new vaccine journal Health Aff Millwood ... of a Meningococcal Serogroup A Conjugate Vaccine journal Clin Vaccine Immunol volume 18 issue ... more details
ChemSpiderID NA DrugBank Ref drugbankcite correct drugbank Chemical data Hepatitis A vaccine is a vaccine against the hepatitis A virus. The first successful vaccine against it was invented by Maurice ... X year 2007 page 107 ref The vaccine protects against the virus in more than 95 of cases and provides ... http linkinghub.elsevier.com retrieve pii S0140 6736 03 14418 2 ref . The vaccine contains inactivated ... 2007 03 12 ref The vaccine was first phased in around 1996 for children living in high risk areas. In 1999, it was spread to areas with elevating levels of infection. Today, in the U.S., the vaccine ... Immunization info cite web title Hepatitis A Vaccine Information work Vaccine Information publisher ImmunizationInfo url http www.immunizationinfo.org vaccineInfo vaccine detail.cfv?id 3 accessdate ... name CDC 2006 cite web title Hepatitis A Vaccine What you need to know work Vaccine Information Statement ... accessdate 2007 03 12 ref Hepatitis A is the most common vaccine preventable virus acquired during travel ...?articleId 667 Bot retrieved archive archivedate 2007 03 10 ref The vaccine should be given in the muscle of the upper arm and be given in two doses for the best protection. The initial dose of the vaccine ... Havrix vaccine. This may not be a comprehensive list of all commercial Hepatitis A vaccines available ... and VIROHEP A. This vaccine consists of Virus like Particle virosomes , artificial particles composed ... Use dmy dates date June 2011 DEFAULTSORT Hepatitis A Vaccine Category Vaccines ... more details
Multiple issues orphan July 2008 expert Veterinary medicine refimprove July 2008 date March 2009 A marker vaccine is a vaccine which allows for the differentiation between infected and vaccinated subjects. Most vaccines are inactivated or attenuated forms of the targeted virus , therefore it is impossible to differentiate by laboratory tests which subjects are infected or only vaccinated. Marker vaccines, being a form of the virus without a particular gene coding for a non protective antigen so, do not produce a key antibody , while still protecting against the disease . Laboratory tests can test for the absence of the antibody, confirming whether the individual has vaccinated or is genuinely infected and needs treatment. References http www.ibr marker.com Marker vaccine.asp Infectious bovine rhinotracheitis marker vaccines Category Vaccination Immunology stub de Markerimpfstoff ... more details
A Trypanosomiasis vaccine is a vaccine against trypanosomiasis . No effective vaccine currently exists, but development of a vaccine is the subject of current research. The Bill & Melinda Gates Foundation has been involved in funding research. ref name urlUS Fraunhofer Center receives Grant from the Bill & Melinda Gates Foundation Intellectual Property cite web url http www.kooperation international.de en countries geistiges eigentum info detail data 6805 title US Fraunhofer Center receives Grant from the Bill & Melinda Gates Foundation Intellectual Property format work accessdate 2009 01 15 ref There are many obstacles to development of such a vaccine. One obstacle is variant surface glycoprotein which makes it difficult for the immune system to recognize the infectious organism. ref name pmid18936180 cite journal author Dagenais TR, Demick KP, Bangs JD, Forest KT, Paulnock DM, Mansfield JM title T Cell Responses to the Trypanosome Variant Surface Glycoprotein Are Not Limited to Hypervariable Subregions journal Infect. Immun. volume 77 issue 1 pages 141 51 year 2009 month January pmid 18936180 doi 10.1128 IAI.00729 08 url http iai.asm.org cgi pmidlookup?view long&pmid 18936180 pmc 2612290 ref Also, Trypanosoma brucei has a direct inhibitory effect upon B cell s. ref name pmid18516300 cite journal author Radwanska M, Guirnalda P, De Trez C, Ryffel B, Black S, Magez S title Trypanosomiasis Induced B Cell Apoptosis Results in Loss of Protective Anti Parasite Antibody Responses and Abolishment of Vaccine Induced Memory Responses journal PLoS Pathog. volume 4 issue 5 pages e1000078 year 2008 month May pmid 18516300 pmc 2386555 doi 10.1371 journal.ppat.1000078 url http www.plospathogens.org article info doi 10.1371 journal.ppat.1000078 editor1 last Riley editor1 first Eleanor M. ref One strategy may involve a vaccine against the initial antigens. ref name urlTrypanosomiasis ... from Trypanosoma congolense drug target and vaccine candidate journal Biol. Chem. volume 383 issue ... more details
File Hookworms.JPG thumb right Hookworm Hookworm vaccine is a vaccine against hookworm . ref name pmid18171264 ... E title The End of the Line for Hookworm? An Update on Vaccine Development journal PLoS Med. volume ... about drug resistance developing in hookworms against the commonly used treatments, thus a vaccine ... this would suggest that vaccine development may be difficult, successful hookworm vaccines have been developed for several animal species. ref name pmid18171264 On the basis of prior work, human vaccine ... cycle a combined vaccine for humans that would provide more complete protection against hookworm infection ... Na ASP 2 vaccine candidate characterization of humoral and cellular responses after vaccination ... controlled, double blind trial of the Na ASP 2 hookworm vaccine in unexposed adults journal Vaccine ... in human clinical trials journal Vaccine volume 23 issue 39 pages 4754 64 year 2005 month September ... 410X 05 00511 6 ref The class of proteins that includes Na ASP 2, ASPs, are promising vaccine candidates based on previous vaccine studies in sheep, guinea pigs, cattle, and mice, which have demonstrated ... vaccine for human hookworm disease the Human Hookworm Vaccine Initiative journal Int. J. Parasitol. volume ... for current research efforts to develop hookworm vaccines has come from the Human Hookworm Vaccine ... of vaccines against neglected tropical diseases a vaccine against human hookworm journal Expert Rev ... id ori rid crossref.org&rfr dat cr pub 3dncbi.nlm.nih.gov ref a program of the Sabin Vaccine Institute ... of Hygiene and Tropical Medicine . ref name pmid16187734 ref name SabinHHVI http sabin.org vaccine development vaccines hookworm Human Hookworm Vaccine Initiative Overview , Sabin Vaccine Institute ref ref name WHO World Health Organization , Initiative for Vaccine Research, http www.who.int vaccine research diseases soa parasitic en index2.html Hookworm disease ref Funding for hookworm vaccine ... Poverty Cycle Genomics and Innovative Partnerships are Key to Parasitic and Bacterial Vaccine Development ... more details
Drugbox Verifiedfields changed verifiedrevid 450061491 image Poliodrops.jpg Vacine data type vaccine target Polio virus vaccine type killed Clinical data Drugs.com drugs.com MTM polio vaccine pregnancy ... drugbank DrugBank Chemical data Two polio vaccine s are used throughout the world to combat poliomyelitis ... . An oral vaccine was developed by Albert Sabin using Attenuated virus attenuated poliovirus. Clinical trial Human trials of Sabin s vaccine began in 1957 and it was licensed in 1962. ref cite web title ... I title Transmissibility and persistence of oral polio vaccine viruses implications for the global ... to 1,652 cases in 2007. ref name eradication cite journal title Update on vaccine derived polioviruses ... W, Pallansch M title Vaccine derived polioviruses and the endgame strategy for global polio eradication ... poliovirus, thereby protecting both individual vaccine recipients and herd immunity the wider community ... to produce a formaldehyde killed polio vaccine from ground up monkey spinal cord s. His initial attempts were hampered by the difficulty of obtaining enough virus. Brodie first tested the vaccine on himself and several of his assistants. He then gave the vaccine to three thousand children, many of whom ... to have developed a vaccine that same year, but it too produced no immunity and was blamed for causing ... facilitated vaccine research and ultimately allowed for the development of vaccines against polio ... vaccine by commercial interests, including Lederle Laboratories in New York under the direction ... , who claims to have created the first successful polio vaccine, in 1950. His vaccine, however, being ... until five years after Jonas Salk s polio vaccine a dead injectable vaccine had reached the market. Koprowski s attenuated vaccine was prepared by successive passages through the brains of Swiss albino mice. By the seventh passage, the vaccine strains could no longer infect nervous tissue or cause paralysis. After one to three further passages on rats, the vaccine was deemed safe for human use ... more details
A Schistosomiasis vaccine is a vaccine against Schistosomiasis also known as bilharzia , bilharziosis or snail fever , a parasitic disease caused by several species of Trematoda fluke of the genus Schistosoma . Schistosomiasis affects over 200 million people worldwide, mainly in rural agricultural and peri urban areas of developing countries , and approximately 10 suffer severe health complications ..., reinfection occurs frequently following drug treatment, thus a vaccine is sought to provide ... Recent advances in vaccine research against schistosomiasis in Brazil year 2008 last1 Oliveira first1 ... model s of schistosomiasis. ref name McManus & Loukas Paramyosin has been proposed as a vaccine ... and Characterization of Paramyosin, a Vaccine Candidate for Schistosomiasis Japonica year 2008 last1 ... long&pmid 17297052 year 2007 title Antibody isotype responses to paramyosin, a vaccine candidate for schistosomiasis ... is the sole schistosome vaccine candidate that has been tested for its prophylactic and antifecundity efficacy in different vaccine formulations and approaches e.g., DNA alone, recombinant protein .... Sm p80 based vaccine formulation s have four effects Reduction in adult worm numbers Reduction ... against acute schistosomiasis Therapeutic effect on adult worms. This vaccine is now now ready ... Efficacy Testing of Sm p80 Based Vaccine in a Nonhuman Primate Model of Schistosoma mansoni Infection ... vaccine year 2009 last1 Ahmad first1 Gul last2 Zhang first2 Weidong last3 Torben first3 Workineh ... of Sm14 as a schistosomiasis vaccine year 2008 last1 Tendler first1 Miriam last2 Simpson first2 Andrew ... vaccines has come from the Schistosomiasis Vaccine Initiative, a program of the Sabin Vaccine Institute ... of Hygiene and Tropical Medicine . ref name SabinSVI http sabin.org vaccine development vaccines schisto Schistosomiasis Overview , Sabin Vaccine Institute ref References Reflist 2 External links ClinicalTrialsGov NCT00870649 Efficacy of Vaccine Sh28GST in Association With Praziquantel PZQ for Prevention ... more details
Drugbox Verifiedfields changed verifiedrevid 448003467 Vacine data type vaccine target rotavirus vaccine ... ChemSpiderID NA ATC prefix J07 ATC suffix BH02 Chemical data A rotavirus vaccine protects children ... approach to rotavirus vaccine introduction in developing countries journal BMC Public Health volume ... that rotavirus vaccine be included in all national immunization programs. The Rotavirus Vaccine ... of rotavirus vaccines in developing countries. The Rotavirus Vaccine Program is a collaboration ... http www.rotavirus.org PATH s Rotavirus Vaccine Program ref History In 1998 a rotavirus vaccine .... The manufacturer of the vaccine, however, withdrew it from the market in 1999, after it was discovered that the vaccine may have contributed to an increased risk for Intussusception medical disorder ... debate about the relative risks and benefits of a rotavirus vaccine. ref name pmid16099078 cite journal author Bines J title Intussusception and rotavirus vaccines journal Vaccine volume 24 issue ... vaccine journal Expert review of vaccines volume 6 issue 1 pages 11 9 year 2007 pmid 17280473 doi ... author Matson DO title The pentavalent rotavirus vaccine, RotaTeq journal Seminars in paediatric ... attenuated rotavirus vaccine containing a rotavirus strain of G1P 8 specificity. ROTARIX is indicated ... O Ryan M title Rotarix RIX4414 an oral human rotavirus vaccine journal Expert Rev Vaccines volume 6 ..., vaccines are supposed to be sterile. Since there was a competing vaccine against diarrhea ... of caution. In May 2010 the suspension of the vaccine was lifted. ref FDA s MedWatch Safety Alerts ... 20Lifted Rotarix Vaccine Suspension Lifted ref RotaTeq File Clark Offit rotavirus inventors.jpeg ... vaccine that contains five rotaviruses produced by reassortment . The rotavirus A parent strains of the reassortants ... is working with a range of partners including the Rotavirus Vaccine Program, PATH, Program for Appropriate ... mechanisms for providing access to this vaccine in the developing world. ref name pmid12598149 ... more details
cleanup date December 2011 Drugbox verifiedrevid 415806441 Vacine data type vaccine target Clostridium tetani vaccine type toxoid Clinical data tradename MedlinePlus a682198 pregnancy AU A B1 B2 B3 C D ... 2009 04 23 quote Tetanus vaccine is a vaccine composed of inactivated tetanus toxin with formaldehyde . This vaccine is imumunogenic not pathogenic and is used to prevent an individual from contracting ... tetanus toxoid was discovered and produced in 1924. This vaccine was proven to be successful when ... Tetanus Vaccine Questions and Answers url http www.vaccineinformation.org tetanus qandavax.asp accessdate 16 Nov. 2011 ref DPT vaccine DTP which is the vaccine for diphtheria , tetanus, and pertussis ... which included the acellular pertussis vaccine because of safety concerns. Half of those who received the DTP vaccine had redness, swelling, and pain around the injection site ref name VaccInfo which is why this vaccine was replaced. There was a production of two new vaccines in 2005. These combined ... as opposed to previously when the vaccine was only given to children . ref name VaccInfo Vaccination ... vaccine is administered at infancy. The baby is injected with the DTaP vaccine which is 3 inactive toxins in one injection. DTaP protects against diphtheria, pertussis, and tetanus. This vaccine is safer than the previously used DTP. ref name Tetanus Another option for infants is DT vaccine DT which is a vaccine that is a combination of diphtheria and tetanus vaccines. This is given as an alternative to infants who have conflicts with the DTaP vaccine. ref name VaccInfo Booster shots Booster .... This is because after the introduction of the vaccine when lymphocyte production is high ... of these booster shots should be Tdap while the rest are Td. ref name VaccInfo Procedure Each vaccine ... diphtheria acellular Pertussis Vaccine Tdap Less than 2 Years following Previous Tetanus Vaccination ... by the National Childhood Vaccine Injury Act of 1986. ref name Roush07 cite journal author Roush ... more details
orphan date May 2008 Hectivac P is a vaccine for sheep in the United Kingdom that protects sheep against 7 clostridial diseases and pneumonia non human pneumonia . It should be administered subcutaneously at least 4 weeks before lambing. This results in the specific antibodies being produced by B cell B cells and secreted into the mammary glands . These antibodies in the colostrum of the vaccinated sheep provide immunity to her lambs. Booster injections are required to sustain immunity. Category Vaccines Veterinary med stub ... more details
Encyclopedia
top
